semaglutide cardiovascular outcomes study news VisualAbstract: and in Obesity without Diabetes π¨ Breaking News: Real-World Data
Description
After 72 hours of treatment, cells were stained with trypan blue, and live/dead cells were quantified on a cellometer (Nexcelom Bioscience
Winfrey started taking semaglutide, an antidiabetic and an anti-obesity medication, sometime in 2023
doi:10.1001/jamapsychiatry.2024.3599
PARP: Poly (ADP-ribose) Polymerase
Kuttapitiya, A
Meta-analyses have shown that the amount of weight regained after stopping treatment is typically proportional to the initial weight loss, and lifestyle interventions become increasingly difficult to maintain once the medication is discontinued (Berg et al., 2025)
